Donald Negroski

Statistics

Publications

Citations

373

H-Index

Active since

1986

Affiliations

Biogen (United States)(Current)

Cleveland Clinic

Center for Innovation

McGill University

Charles University

Donald Negroski is an author at Biogen (United States) specializing in relapsing-remitting multiple sclerosis treatment, multiple sclerosis therapy, and fumarate therapy.

Publications per year

1986–2023

Publications

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold et al. · Neurology Clinical Practice · 2016 · 104 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Amyotrophic lateral sclerosis

Hiroshi Mitsumoto, Efrain Salgado, Donald Negroski et al. · Neurology · 1986 · 83 citations

Life Sciences, Neurology, Neuroscience +14

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study

David H. Miller, Robert J. Fox, J. Theodore Phillips et al. · Neurology · 2015 · 65 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients

Gavin Giovannoni, Jeffrey Cohen, Alasdair Coles et al. · Neurology · 2016 · 62 citations · Full text

Medicine, Neurology, Pharmacotherapy +13

Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study

Sibyl Wray, Florian Then Bergh, Annette Wundes et al. · Advances in Therapy · 2022 · 36 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

1–5 of 6